![Jian Sun](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jian Sun
Corporate Officer/Principal en Lianyuangang Chia Tai Tianqing Medicine Co., Ltd. .
Cargos activos de Jian Sun
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Lianyuangang Chia Tai Tianqing Medicine Co., Ltd. | Corporate Officer/Principal | 19/08/2011 | - |
Historial de carrera de Jian Sun
Antiguos cargos conocidos de Jian Sun.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
![]() Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu. | Presidente | 19/08/2011 | - |
Estadísticas
Internacional
China | 3 |
Operativa
President | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
![]() Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu. | Health Technology |
Lianyuangang Chia Tai Tianqing Medicine Co., Ltd. |
- Bolsa de valores
- Insiders
- Jian Sun
- Experiencia